1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Off-Label 1.2.3 Therapeutic 1.3 Market by Application 1.3.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacy 1.3.3 Online Provider 1.3.4 Retail Pharmacy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Perspective (2016-2027) 2.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Growth Trends by Regions 2.2.1 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Industry Dynamic 2.3.1 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Trends 2.3.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Drivers 2.3.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Challenges 2.3.4 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Revenue 3.1.1 Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Revenue (2016-2021) 3.1.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue 3.4 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Concentration Ratio 3.4.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue in 2020 3.5 Non-Alcoholic Steatohepatitis (NASH) Treatment Key Players Head office and Area Served 3.6 Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Product Solution and Service 3.7 Date of Enter into Non-Alcoholic Steatohepatitis (NASH) Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Non-Alcoholic Steatohepatitis (NASH) Treatment Breakdown Data by Type 4.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Size by Type (2016-2021) 4.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Type (2022-2027) 5 Non-Alcoholic Steatohepatitis (NASH) Treatment Breakdown Data by Application 5.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Size by Application (2016-2021) 5.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2016-2027) 6.2 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type 6.2.1 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2021) 6.2.2 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2022-2027) 6.2.3 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2027) 6.3 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application 6.3.1 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2021) 6.3.2 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2022-2027) 6.3.3 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2027) 6.4 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country 6.4.1 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2016-2021) 6.4.2 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2016-2027) 7.2 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type 7.2.1 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2021) 7.2.2 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2022-2027) 7.2.3 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2027) 7.3 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application 7.3.1 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2021) 7.3.2 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2022-2027) 7.3.3 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2027) 7.4 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country 7.4.1 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2016-2021) 7.4.2 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2016-2027) 8.2 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type 8.2.1 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application 8.3.1 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region 8.4.1 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2016-2027) 9.2 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type 9.2.1 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2027) 9.3 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application 9.3.1 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2027) 9.4 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country 9.4.1 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2016-2027) 10.2 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type 10.2.1 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application 10.3.1 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country 10.4.1 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Allergan Plc (Tobira) 11.1.1 Allergan Plc (Tobira) Company Details 11.1.2 Allergan Plc (Tobira) Business Overview 11.1.3 Allergan Plc (Tobira) Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction 11.1.4 Allergan Plc (Tobira) Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) 11.1.5 Allergan Plc (Tobira) Recent Development 11.2 Bristol Myers Squibb 11.2.1 Bristol Myers Squibb Company Details 11.2.2 Bristol Myers Squibb Business Overview 11.2.3 Bristol Myers Squibb Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction 11.2.4 Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) 11.2.5 Bristol Myers Squibb Recent Development 11.3 Galmed Pharmaceuticals 11.3.1 Galmed Pharmaceuticals Company Details 11.3.2 Galmed Pharmaceuticals Business Overview 11.3.3 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction 11.3.4 Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) 11.3.5 Galmed Pharmaceuticals Recent Development 11.4 Genfit SA 11.4.1 Genfit SA Company Details 11.4.2 Genfit SA Business Overview 11.4.3 Genfit SA Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction 11.4.4 Genfit SA Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) 11.4.5 Genfit SA Recent Development 11.5 Gilead Sciences, Inc. 11.5.1 Gilead Sciences, Inc. Company Details 11.5.2 Gilead Sciences, Inc. Business Overview 11.5.3 Gilead Sciences, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction 11.5.4 Gilead Sciences, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) 11.5.5 Gilead Sciences, Inc. Recent Development 11.6 Intercept Pharmaceuticals, Inc. 11.6.1 Intercept Pharmaceuticals, Inc. Company Details 11.6.2 Intercept Pharmaceuticals, Inc. Business Overview 11.6.3 Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction 11.6.4 Intercept Pharmaceuticals, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) 11.6.5 Intercept Pharmaceuticals, Inc. Recent Development 11.7 Zydus Cadila 11.7.1 Zydus Cadila Company Details 11.7.2 Zydus Cadila Business Overview 11.7.3 Zydus Cadila Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction 11.7.4 Zydus Cadila Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) 11.7.5 Zydus Cadila Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Off-Label Table 3. Key Players of Therapeutic Table 4. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Regions (2016-2021) Table 8. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Regions (2022-2027) Table 10. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Trends Table 11. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Drivers Table 12. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Challenges Table 13. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Restraints Table 14. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Players (2016-2021) Table 16. Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment as of 2020) Table 17. Ranking of Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Product Solution and Service Table 21. Date of Enter into Non-Alcoholic Steatohepatitis (NASH) Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2021) (US$ Million) Table 24. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Type (2016-2021) Table 25. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Application (2016-2021) Table 29. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2021) (US$ Million) Table 32. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2021) (US$ Million) Table 34. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 61. Allergan Plc (Tobira) Company Details Table 62. Allergan Plc (Tobira) Business Overview Table 63. Allergan Plc (Tobira) Non-Alcoholic Steatohepatitis (NASH) Treatment Product Table 64. Allergan Plc (Tobira) Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) & (US$ Million) Table 65. Allergan Plc (Tobira) Recent Development Table 66. Bristol Myers Squibb Company Details Table 67. Bristol Myers Squibb Business Overview Table 68. Bristol Myers Squibb Non-Alcoholic Steatohepatitis (NASH) Treatment Product Table 69. Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) & (US$ Million) Table 70. Bristol Myers Squibb Recent Development Table 71. Galmed Pharmaceuticals Company Details Table 72. Galmed Pharmaceuticals Business Overview Table 73. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Treatment Product Table 74. Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) & (US$ Million) Table 75. Galmed Pharmaceuticals Recent Development Table 76. Genfit SA Company Details Table 77. Genfit SA Business Overview Table 78. Genfit SA Non-Alcoholic Steatohepatitis (NASH) Treatment Product Table 79. Genfit SA Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) & (US$ Million) Table 80. Genfit SA Recent Development Table 81. Gilead Sciences, Inc. Company Details Table 82. Gilead Sciences, Inc. Business Overview Table 83. Gilead Sciences, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Product Table 84. Gilead Sciences, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) & (US$ Million) Table 85. Gilead Sciences, Inc. Recent Development Table 86. Intercept Pharmaceuticals, Inc. Company Details Table 87. Intercept Pharmaceuticals, Inc. Business Overview Table 88. Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Product Table 89. Intercept Pharmaceuticals, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) & (US$ Million) Table 90. Intercept Pharmaceuticals, Inc. Recent Development Table 91. Zydus Cadila Company Details Table 92. Zydus Cadila Business Overview Table 93. Zydus Cadila Non-Alcoholic Steatohepatitis (NASH) Treatment Product Table 94. Zydus Cadila Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) & (US$ Million) Table 95. Zydus Cadila Recent Development Table 96. Research Programs/Design for This Report Table 97. Key Data Information from Secondary Sources Table 98. Key Data Information from Primary Sources List of Figures Figure 1. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type: 2020 VS 2027 Figure 2. Off-Label Features Figure 3. Therapeutic Features Figure 4. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application: 2020 VS 2027 Figure 5. Hospital Pharmacy Case Studies Figure 6. Online Provider Case Studies Figure 7. Retail Pharmacy Case Studies Figure 8. Non-Alcoholic Steatohepatitis (NASH) Treatment Report Years Considered Figure 9. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Regions: 2020 VS 2027 Figure 12. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Regions (2022-2027) Figure 13. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Players in 2020 Figure 14. Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue in 2020 Figure 16. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Type (2016-2021) Figure 17. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Type (2022-2027) Figure 18. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type (2016-2027) Figure 20. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application (2016-2027) Figure 21. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2016-2027) Figure 22. United States Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type (2016-2027) Figure 26. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application (2016-2027) Figure 27. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2016-2027) Figure 28. Germany Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type (2016-2027) Figure 36. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application (2016-2027) Figure 37. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Region (2016-2027) Figure 38. China Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type (2016-2027) Figure 46. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application (2016-2027) Figure 47. Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2016-2027) Figure 48. Mexico Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type (2016-2027) Figure 52. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application (2016-2027) Figure 53. Middle East & Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Country (2016-2027) Figure 54. Turkey Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Allergan Plc (Tobira) Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) Figure 58. Bristol Myers Squibb Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) Figure 59. Galmed Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) Figure 60. Genfit SA Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) Figure 61. Gilead Sciences, Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) Figure 62. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) Figure 63. Zydus Cadila Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2016-2021) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Allergan Plc (Tobira) Bristol Myers Squibb Galmed Pharmaceuticals Genfit SA Gilead Sciences, Inc. Intercept Pharmaceuticals, Inc. Zydus Cadila